Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.11 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 11,000 shares traded.
Resverlogix Trading Down 5.0%
The company has a 50 day moving average of C$0.11 and a two-hundred day moving average of C$0.10. The company has a debt-to-equity ratio of -81.94, a quick ratio of 0.04 and a current ratio of 0.04. The stock has a market capitalization of C$30.04 million, a PE ratio of -3.17 and a beta of 0.72.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Further Reading
- Five stocks we like better than Resverlogix
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
